Search alternatives:
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
wt decrease » _ decrease (Expand Search), awd decreased (Expand Search), step decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
wt decrease » _ decrease (Expand Search), awd decreased (Expand Search), step decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
10961
-
10962
-
10963
-
10964
-
10965
-
10966
Smokefree legislation effects on respiratory and sensory disorders: A systematic review and meta-analysis
Published 2017“…Paired reviewers independently carried out the screening of titles and abstracts, data extraction from full-text articles, and methodological quality assessment.</p><p>Results</p><p>A total number of 1606 papers were identified. 50 papers were selected, 26 were related to symptoms (23 concerned workers). …”
-
10967
Exploring cardiac vector propagation in acute myocardial infarction: a spatial velocity perspective
Published 2024“…</p> <p>VCG was constructed as a space curve directly with three quasi-orthogonal leads I, aVF and V2 recorded by conventional ECG of 25 healthy individuals and 50 AMI patients. …”
-
10968
-
10969
-
10970
-
10971
-
10972
-
10973
Identification of a functional RevRE within the <i>CLOCK</i> gene by EMSA.
Published 2013“…<p>(a) The sequences of the wild-type <i>CLOCK</i> RevRE and mutant <i>CLOCK</i> RevRE are shown. …”
-
10974
-
10975
-
10976
-
10977
-
10978
-
10979
-
10980
DataSheet_1_A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in health...
Published 2024“…Despite some signs of efficacy since then, most rIL-12 clinical trials have encountered hurdles such as short terminal elimination half-life (T<sub>½</sub>), limited tumor microenvironment targeting, and substantial systemic toxicity. We developed a strategy to extend the rIL-12 T<sub>½</sub> that depends on binding albumin in vivo to target tumor tissue, using single-chain rIL-12 linked to a fully human albumin binding (F<sub>H</sub>AB) domain (SON-1010). …”